[{"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-001", "question": "A 27-year-old G1P0 at 9 weeks' gestation presents with intractable nausea and vomiting, 7-kg weight loss, new-onset jaundice, and confusion over 3 days. She has no prior liver disease or alcohol use. Vitals: T 37.2°C, HR 122, BP 100/62, RR 18, SpO2 98% RA. Exam: scleral icterus, moderate right upper quadrant tenderness without rebound, asterixis. Labs: Na 132, K 3.1, bicarbonate 19, creatinine 1.2 mg/dL (baseline 0.6), AST 545 U/L, ALT 510 U/L, ALP 225 U/L, total bilirubin 12.4 mg/dL (direct 8.1), INR 2.6, ammonia 102 µmol/L, β-hCG markedly elevated for gestational age, thyroid studies: TSH low, free T4 and T3 mildly elevated. Abdominal ultrasound: single live intrauterine pregnancy, normal hepatic and portal vasculature, no biliary dilation, mild fatty liver change. Viral hepatitis serologies and autoimmune markers are pending. She is receiving IV fluids and antiemetics but continues to deteriorate neurologically. Which of the following is the most appropriate immediate next management step?", "options": ["Administer high-dose IV methylprednisolone and defer pregnancy decisions until serologies return", "Urgently proceed with uterine evacuation and initiate N-acetylcysteine infusion", "Start high-dose IV thiamine and parenteral nutrition while continuing pregnancy", "List for emergent liver transplantation without altering pregnancy status", "Administer propylthiouracil and beta-blockers to treat probable gestational thyrotoxicosis and reassess"], "answer": "B", "answer_index": 1, "explanation": "This presentation is most consistent with hyperemesis gravidarum-associated acute liver failure with encephalopathy and coagulopathy; maternal survival takes precedence, and rapid uterine evacuation plus N-acetylcysteine offers the best chance to reverse fulminant hepatic injury. Steroids (A) address autoimmune hepatitis, which is unconfirmed and too slow. Thiamine and nutrition (C) are supportive but insufficient in fulminant failure with encephalopathy. Immediate transplantation listing (D) may be needed but should follow rapid removal of the precipitating factor. Treating mild gestational thyrotoxicosis alone (E) will not address the primary life-threatening hepatic process.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: first-trimester pregnancy, intractable nausea/vomiting, severe acute liver injury (elevated AST/ALT, coagulopathy, encephalopathy), absence of other acute liver failure etiologies on initial workup, and failure to improve with supportive care. The item logically points to hyperemesis gravidarum leading to acute liver failure, where immediate termination of pregnancy is a recognized life-saving intervention. No internal contradictions exist; the keyed answer (urgent uterine evacuation and N-acetylcysteine) is the single best, guideline-supported step. Medical accuracy is sound: acute liver failure in early pregnancy with hyperemesis is an indication for pregnancy termination to reverse the process. Minor nuance: N-acetylcysteine is not universally standard for non-acetaminophen acute liver failure in pregnancy, but its use is plausible. Minimal fix: none required for logical validity; to enhance precision, specify 'acute liver failure due to hyperemesis gravidarum' in the rationale.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: first-trimester pregnancy, intractable nausea/vomiting, severe acute liver injury (elevated AST/ALT, coagulopathy, encephalopathy), absence of other acute liver failure etiologies on initial workup, and failure to improve with supportive care. The item logically points to hyperemesis gravidarum leading to acute liver failure, where immediate termination of pregnancy is a recognized life-saving intervention. No internal contradictions exist; the keyed answer (urgent uterine evacuation and N-acetylcysteine) is the single best, guideline-supported step. Medical accuracy is sound: acute liver failure in early pregnancy with hyperemesis is an indication for pregnancy termination to reverse the process. Minor nuance: N-acetylcysteine is not universally standard for non-acetaminophen acute liver failure in pregnancy, but its use is plausible. Minimal fix: none required for logical validity; to enhance precision, specify 'acute liver failure due to hyperemesis gravidarum' in the rationale.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-002", "question": "A 63-year-old man with long-standing hypertension and ischemic cardiomyopathy (EF 30%) presents with acute right hemiplegia and aphasia 45 minutes after symptom onset. NIHSS is 18. Noncontrast CT head shows no hemorrhage. CT angiography shows left M1 occlusion with favorable collaterals; CT perfusion suggests a large salvageable penumbra. ECG shows sinus rhythm with frequent PVCs. High-sensitivity troponin is mildly elevated and flat on serial testing. You plan IV thrombolysis and urgent mechanical thrombectomy. Which of the following additional acute management steps is most appropriate?", "options": ["Initiate IV unfractionated heparin infusion before mechanical thrombectomy due to high cardioembolic risk", "Administer IV labetalol to reduce blood pressure to <140/90 mm Hg prior to thrombolysis", "Start high-dose statin and delay any antiplatelet therapy until 24 hours after thrombolysis", "Begin dual antiplatelet therapy with aspirin and clopidogrel immediately after thrombolysis", "Place an intra-aortic balloon pump preemptively to support cerebral perfusion during thrombectomy"], "answer": "C", "answer_index": 2, "explanation": "The correct step is to start high-intensity statin immediately and delay antiplatelets until 24 hours after thrombolysis and repeat imaging, per acute ischemic stroke guidelines. Heparin before thrombectomy (A) increases hemorrhagic risk with no proven benefit. Lowering BP below 140/90 (B) before tPA is too aggressive and can worsen cerebral perfusion; only treat if >185/110 to that threshold. Dual antiplatelets immediately after tPA (D) markedly increases hemorrhage risk. Intra-aortic balloon pump (E) has no role in this setting and carries procedural risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: acute ischemic stroke with large vessel occlusion, eligible for IV tPA and thrombectomy, no hemorrhage, mild troponin elevation. The keyed answer (C) is not the single best answer. While starting a statin is appropriate, the instruction to delay antiplatelets for 24 hours is not the most critical acute management step. The most appropriate immediate step is to manage blood pressure per tPA protocol (treat only if >185/110), making option B the best answer, though it is incorrectly aggressive in its target. Main logical issue: Key mismatch. Main medical issue: Option B's target of <140/90 is too low pre-tPA, but its core action (managing BP) is the priority. Option C's antiplatelet delay is guideline-correct but not the most urgent 'additional step.' Minimal fix: Change key to B and revise its BP target to 'treat only if systolic >185 mm Hg to reduce to <185/110.'\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: acute ischemic stroke with large vessel occlusion, eligible for IV tPA and thrombectomy, no hemorrhage, mild troponin elevation. The keyed answer (C) is not the single best answer. While starting a statin is appropriate, the instruction to delay antiplatelets for 24 hours is not the most critical acute management step. The most appropriate immediate step is to manage blood pressure per tPA protocol (treat only if >185/110), making option B the best answer, though it is incorrectly aggressive in its target. Main logical issue: Key mismatch. Main medical issue: Option B's target of <140/90 is too low pre-tPA, but its core action (managing BP) is the priority. Option C's antiplatelet delay is guideline-correct but not the most urgent 'additional step.' Minimal fix: Change key to B and revise its BP target to 'treat only if systolic >185 mm Hg to reduce to <185/110.'", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-003", "question": "A 34-year-old woman with SLE (malar rash, arthritis, class III lupus nephritis on biopsy) on mycophenolate and low-dose prednisone presents with 3 months of progressive exertional dyspnea and dry cough. She has no smoking history. Vitals: HR 96, BP 112/70, RR 18, SpO2 94% RA. Exam: fine bibasilar crackles, no peripheral edema. Labs: creatinine 1.0 mg/dL, ANA 1:640 homogeneous, anti-dsDNA mildly elevated, complements low, ESR 18 mm/hr, CRP 2 mg/L. PFTs: FVC 65% predicted, FEV1/FVC 0.82, DLCO 40% predicted. HRCT: diffuse ground-glass opacities with scattered areas of consolidation and traction bronchiectasis, predominantly in lower lobes, no honeycombing. BAL: lymphocytic predominance, cultures negative. Echocardiogram: normal LV function, PASP 30 mm Hg. Which of the following is the most appropriate next step in management?", "options": ["Escalate mycophenolate dose and add high-dose oral prednisone without further diagnostics", "Switch mycophenolate to cyclophosphamide and simultaneously list for lung transplantation", "Perform surgical lung biopsy to distinguish organizing pneumonia from NSIP", "Add rituximab while continuing mycophenolate at the same dose", "Initiate nintedanib in addition to current immunosuppression for progressive fibrosing ILD"], "answer": "E", "answer_index": 4, "explanation": "This is SLE-associated progressive fibrosing interstitial lung disease with traction bronchiectasis and physiologic restriction despite immunosuppression; nintedanib has evidence for slowing decline in progressive fibrosing ILDs, including CTD-ILD. Blind escalation of steroids/mycophenolate (A) risks toxicity without clear additional benefit. Routine upfront lung transplant listing (B) is premature. Lung biopsy (C) is high risk and unlikely to alter management given established CTD-ILD pattern. Rituximab (D) can be considered, but antifibrotic therapy specifically targets the progressive fibrosing phenotype and is strongly indicated here.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: SLE with class III nephritis, progressive dyspnea, dry cough, bibasilar crackles, PFTs showing restriction and low DLCO, HRCT showing ground-glass opacities, consolidation, and traction bronchiectasis (no honeycombing), BAL lymphocytic, normal echo. The findings are classic for an active, inflammatory interstitial lung disease (likely NSIP or OP pattern) in the context of SLE, not an end-stage fibrotic disease. The logical issue is miskeying: the unique best answer is immunosuppression escalation (A or D), not initiating an antifibrotic (E). Nintedanib is for progressive fibrosing ILD with a predominant fibrotic phenotype, which is not established here (no honeycombing, HRCT shows active inflammation). Medical accuracy issue: recommending nintedanib as first-line for this inflammatory presentation contradicts standard management. Minimal fix: Change key to A or D, or significantly alter the vignette to describe a predominantly fibrotic, non-responsive ILD.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: SLE with class III nephritis, progressive dyspnea, dry cough, bibasilar crackles, PFTs showing restriction and low DLCO, HRCT showing ground-glass opacities, consolidation, and traction bronchiectasis (no honeycombing), BAL lymphocytic, normal echo. The findings are classic for an active, inflammatory interstitial lung disease (likely NSIP or OP pattern) in the context of SLE, not an end-stage fibrotic disease. The logical issue is miskeying: the unique best answer is immunosuppression escalation (A or D), not initiating an antifibrotic (E). Nintedanib is for progressive fibrosing ILD with a predominant fibrotic phenotype, which is not established here (no honeycombing, HRCT shows active inflammation). Medical accuracy issue: recommending nintedanib as first-line for this inflammatory presentation contradicts standard management. Minimal fix: Change key to A or D, or significantly alter the vignette to describe a predominantly fibrotic, non-responsive ILD.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-004", "question": "A 51-year-old woman with poorly controlled type 2 diabetes and prior pelvic radiation for cervical cancer presents with 5 days of fever, worsening lower abdominal pain, and foul vaginal discharge. She is hypotensive and tachycardic. Exam: diffuse lower abdominal tenderness with guarding, necrotic friable tissue at the posterior vaginal fornix with gas bubbles and crepitus extending toward the rectovaginal septum. Labs: WBC 19,000/µL, lactate 4.5 mmol/L, creatinine 2.1 mg/dL. CT abdomen/pelvis with contrast: extensive gas in the pelvis tracking along fascial planes into the perineum, no discrete drainable collection, suspected uterine and vaginal wall necrosis. Blood cultures are drawn, and broad-spectrum IV antibiotics and aggressive fluids are started. Which is the most appropriate next step?", "options": ["Urgent total abdominal hysterectomy with wide radical debridement of necrotic pelvic and perineal tissue", "Percutaneous CT-guided drainage of gas-containing pelvic spaces plus continued maximal antibiotics", "Hyperbaric oxygen therapy as a temporizing measure before any surgical intervention", "Emergent exploratory laparotomy limited to diagnostic assessment and peritoneal lavage", "Conservative management with antibiotics and close ICU monitoring to avoid worsening radiation injury"], "answer": "A", "answer_index": 0, "explanation": "The clinical picture is necrotizing pelvic soft tissue infection (type I Fournier-like process) involving uterus and vagina in a radiated field, requiring immediate radical surgical debridement including hysterectomy. Percutaneous drainage (B) is inadequate for necrotizing fasciitis. Hyperbaric oxygen (C) may be adjunctive but never replaces urgent debridement. Exploratory laparotomy without aggressive debridement (D) fails to control source. Conservative management (E) carries an almost universally fatal risk in necrotizing infections.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: poorly controlled diabetes, prior pelvic radiation, necrotic friable vaginal tissue with gas/crepitus, CT showing gas tracking along fascial planes without a discrete abscess, and signs of severe sepsis (hypotension, lactic acidosis). This describes a life-threatening necrotizing soft tissue infection (likely synergistic post-radiation infection) requiring immediate source control. Main logical issue: None; the stem clearly points to a surgical emergency. Main medical accuracy issue: None; the urgency of radical debridement for necrotizing infection is standard. Minimal fix: None required; the item is clear and accurate. Alternatives are correctly inferior: B (drainage inadequate for necrotizing infection), C (adjunct only), D (inadequate debridement), E (fatal delay).\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: poorly controlled diabetes, prior pelvic radiation, necrotic friable vaginal tissue with gas/crepitus, CT showing gas tracking along fascial planes without a discrete abscess, and signs of severe sepsis (hypotension, lactic acidosis). This describes a life-threatening necrotizing soft tissue infection (likely synergistic post-radiation infection) requiring immediate source control. Main logical issue: None; the stem clearly points to a surgical emergency. Main medical accuracy issue: None; the urgency of radical debridement for necrotizing infection is standard. Minimal fix: None required; the item is clear and accurate. Alternatives are correctly inferior: B (drainage inadequate for necrotizing infection), C (adjunct only), D (inadequate debridement), E (fatal delay).", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-005", "question": "A 76-year-old man with permanent atrial fibrillation on apixaban, CKD stage 3b, and prior TIA undergoes TAVR for symptomatic severe aortic stenosis. Preprocedure echo: EF 55%, no intracardiac thrombus, moderate MAC, mild-moderate MR. Postprocedure, he develops acute severe dyspnea and hypotension 2 hours later. Echo: hyperdynamic LV with near-complete mid-cavity obliteration in systole, peak LVOT gradient 80 mm Hg, systolic anterior motion (SAM) of the mitral valve, severe MR, intact TAVR function. Which of the following is the most appropriate immediate management?", "options": ["Start high-dose IV furosemide and nitroprusside to rapidly reduce preload and afterload", "Administer aggressive IV crystalloids and start a phenylephrine infusion while reducing inotropes", "Urgently return to the cath lab for balloon post-dilatation of the TAVR prosthesis", "Begin IV milrinone infusion to augment contractility and improve forward flow", "Perform emergent surgical myectomy with mitral valve repair"], "answer": "B", "answer_index": 1, "explanation": "This is dynamic LVOT obstruction with SAM and severe MR precipitated by TAVR and low preload; management mirrors hypertrophic obstructive physiology-volume expansion and pure alpha-agonist (phenylephrine) to increase afterload while avoiding inotropes. Diuresis and vasodilators (A) and inotropes (D) worsen obstruction. Post-dilatation of the valve (C) is not indicated as prosthetic function is normal. Emergent surgery (E) is reserved for refractory cases after optimal medical hemodynamic management has failed.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: acute severe dyspnea/hypotension post-TAVR, echo showing hyperdynamic LV, mid-cavity obliteration, SAM, severe MR, and high LVOT gradient, with intact prosthesis. This defines dynamic LVOT obstruction. Main logical issue: None; the stem provides all necessary findings to diagnose and manage post-TAVR SAM. Main medical accuracy issue: None; the management aligns with standard guidelines for acute SAM: volume and vasoconstrictors (phenylephrine) while avoiding inotropes and diuretics. Minimal fix: None required; the item is clear and accurate. Alternatives are correctly ruled out: A and D worsen obstruction, C is unnecessary (normal valve), and E is not first-line.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 859)"}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-006", "question": "A 42-year-old man who injects drugs presents with 10 days of fever, severe back pain, and new right leg weakness. Vitals: T 38.8°C, HR 108, BP 122/74. Exam: midline lumbar tenderness, right leg 3/5 strength with hyperreflexia, left leg 5/5, intact sensation, no bowel/bladder symptoms. Labs: WBC 15,000/µL, ESR 96 mm/hr, CRP 120 mg/L. Blood cultures: MRSA in 2/2 sets. MRI lumbar spine with contrast: dorsal epidural collection L2-L4 with significant canal compromise and enhancement consistent with epidural abscess, plus adjacent vertebral osteomyelitis; no discrete psoas abscess. He is started on IV vancomycin. Neurosurgery feels surgery is high risk due to severe cardiomyopathy (EF 20%) and active drug use, recommending medical therapy unless deterioration. What is the most appropriate next step?", "options": ["Continue IV vancomycin alone with close neurologic monitoring for at least 6 weeks", "Add rifampin to vancomycin to enhance penetration into epidural space and bone", "Perform urgent surgical decompression and drainage despite high perioperative risk", "Switch to daptomycin plus ceftaroline to provide broader MRSA coverage", "Place percutaneous CT-guided drain into the epidural collection to avoid open surgery"], "answer": "C", "answer_index": 2, "explanation": "He has spinal epidural abscess with evolving motor deficit and significant canal compromise; urgent surgical decompression and drainage is indicated despite elevated operative risk, as delay risks permanent paralysis. Medical therapy alone (A, B, D) is inadequate once neurologic deficits are present. Percutaneous drainage (E) is not appropriate for epidural abscess causing cord compression, as it rarely achieves effective decompression or safe access to the epidural space.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). The keyed answer (C) contradicts the explicit recommendation from neurosurgery, who advises against surgery due to high risk (severe cardiomyopathy, active drug use) and recommends medical therapy unless deterioration. The stem states surgery is high risk and neurosurgery recommends medical therapy, making C indefensible as the 'most appropriate next step' given the presented information. The best answer is likely A (continue IV vancomycin with monitoring) as it aligns with the specialist recommendation and the absence of acute deterioration. The main logical issue is miskeying; the stem explicitly contradicts the key. Medical accuracy is sound regarding the severity of the condition, but the key ignores the provided risk assessment. Minimal fix: Change the key to A, or revise the neurosurgery recommendation to align with urgent surgery if that is the intended teaching point.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1033)"}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-007", "question": "A 31-year-old woman presents with severe headaches, transient visual obscurations, and pulsatile tinnitus 6 months postpartum. She has gained 20 kg during and after pregnancy. BMI is 38 kg/m². Exam: bilateral papilledema, full strength, no focal deficits. MRI brain with and without contrast is normal. MRV shows smooth tapering and non-visualization of the terminal right transverse sinus with small caliber sigmoid sinus and jugular bulb; the left transverse sinus is dominant and widely patent. Lumbar puncture: opening pressure 34 cm H₂O, normal CSF studies. She is started on acetazolamide and advised weight loss but continues to have progressive visual field loss on serial perimetry over 8 weeks. What is the most appropriate next step in management?", "options": ["Place a ventriculoperitoneal shunt to lower intracranial pressure", "Perform right transverse sinus stenting across the narrowed segment", "Initiate high-dose oral topiramate instead of acetazolamide", "Perform optic nerve sheath fenestration to protect vision", "Start therapeutic anticoagulation for presumed chronic venous sinus thrombosis"], "answer": "D", "answer_index": 3, "explanation": "The patient has idiopathic intracranial hypertension with rapidly progressive visual loss despite maximal medical therapy; optic nerve sheath fenestration is the preferred intervention to promptly protect vision. VP shunting (A) is an option but has higher long-term failure and complication rates and is usually considered after or when ONSF is not feasible. Transverse sinus stenting (B) is usually reserved for documented significant pressure gradients and bilateral or dominant-sided stenosis; here the right sinus is small and nondominant. Topiramate (C) is an adjunct but insufficient alone given progressive visual decline. Anticoagulation (E) is not indicated without imaging evidence of thrombosis.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: Idiopathic intracranial hypertension (IIH) with progressive visual loss despite acetazolamide and weight loss. The vignette describes unilateral nondominant transverse sinus narrowing, not thrombosis, and progressive vision loss despite medical therapy. The most appropriate next step for vision-threatening IIH refractory to medical therapy is typically optic nerve sheath fenestration (ONSF) or CSF diversion (shunt). However, the provided key (D) is ONSF, which is a valid option, but ventriculoperitoneal shunt (A) is also a valid and commonly accepted next step in this scenario, and the vignette does not provide sufficient detail to uniquely favor ONSF over shunt. Both are guideline-supported interventions for refractory IIH with vision loss, leading to ambiguity. The item is miskeyed because the stem does not justify D as the singular best answer over A. Minimal fix: Specify a contraindication to shunt (e.g., 'patient refuses invasive intracranial procedure') or a specific indication for ONSF (e.g., 'headaches are well-controlled, but visual fields are worsening') to make D uniquely best.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: Idiopathic intracranial hypertension (IIH) with progressive visual loss despite acetazolamide and weight loss. The vignette describes unilateral nondominant transverse sinus narrowing, not thrombosis, and progressive vision loss despite medical therapy. The most appropriate next step for vision-threatening IIH refractory to medical therapy is typically optic nerve sheath fenestration (ONSF) or CSF diversion (shunt). However, the provided key (D) is ONSF, which is a valid option, but ventriculoperitoneal shunt (A) is also a valid and commonly accepted next step in this scenario, and the vignette does not provide sufficient detail to uniquely favor ONSF over shunt. Both are guideline-supported interventions for refractory IIH with vision loss, leading to ambiguity. The item is miskeyed because the stem does not justify D as the singular best answer over A. Minimal fix: Specify a contraindication to shunt (e.g., 'patient refuses invasive intracranial procedure') or a specific indication for ONSF (e.g., 'headaches are well-controlled, but visual fields are worsening') to make D uniquely best.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-008", "question": "A 29-year-old woman with a history of two early first-trimester miscarriages and one unexplained fetal demise at 28 weeks presents for preconception counseling. She has livedo reticularis and episodes of digital ischemia in cold weather. Labs: platelets 110,000/µL, hemoglobin 11.5 g/dL, creatinine 0.9 mg/dL. Coagulation profile is normal. aPTT is mildly prolonged. Lupus anticoagulant is repeatedly positive; anticardiolipin IgG and anti-β2-glycoprotein I IgG are high-titer on two occasions 12 weeks apart. She has no personal history of venous or arterial thrombosis. Which of the following is the most appropriate pregnancy management plan?", "options": ["Low-dose aspirin alone starting preconception, escalate to prophylactic LMWH only if thrombosis occurs", "Therapeutic-dose LMWH plus low-dose aspirin starting at positive pregnancy test and continuing 6 weeks postpartum", "Prophylactic-dose LMWH plus low-dose aspirin starting at conception and stopping at delivery", "Low-dose aspirin only during pregnancy, with postpartum prophylactic LMWH for 6 weeks", "No anticoagulation unless she develops hypertensive disorders of pregnancy"], "answer": "B", "answer_index": 1, "explanation": "She meets criteria for high-risk obstetric antiphospholipid syndrome with recurrent pregnancy loss and triple-positive aPL; therapeutic-dose LMWH plus low-dose aspirin throughout pregnancy and 6 weeks postpartum provides optimal maternal and fetal protection. Aspirin alone (A, D, E) is inadequate in high-risk APS. Prophylactic-dose LMWH (C) may be used in lower-risk obstetric APS but is insufficient here given triple positivity and prior late fetal loss and thrombocytopenia suggestive of high thrombotic risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: triple-positive antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-β2-glycoprotein I), prior late fetal demise, recurrent early losses, and thrombocytopenia define high-risk obstetric antiphospholipid syndrome (APS). Main logical issue: None. Main medical accuracy issue: None; the keyed management aligns with major society guidelines (e.g., ACR, EULAR) for high-risk obstetric APS. Minimal fix: None required for logical validity. To enhance clarity, the stem could explicitly state 'high-risk obstetric APS' to preempt debate on risk stratification, though the provided findings are sufficient.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 806)"}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-009", "question": "A 55-year-old man from a region endemic for Lyme disease presents with 1 week of rapidly progressive bilateral leg weakness and numbness ascending from the feet, severe radicular pain, and new urinary retention. He was treated with oral doxycycline 3 weeks ago for erythema migrans following a hiking trip. Exam: symmetric lower extremity weakness 3/5 proximally and distally, hyperreflexia with bilateral Babinski signs, decreased pinprick below T10, preserved vibration sense in toes, and saddle hypesthesia. Cranial nerves are normal. MRI spine with contrast: multifocal enhancing lesions in the thoracic cord with associated leptomeningeal enhancement; no compressive lesion. CSF: WBC 220/µL (80% lymphocytes), protein 120 mg/dL, glucose 45 mg/dL (serum 90), oligoclonal bands present; CSF Lyme antibody index is elevated. HIV, syphilis, and TB tests are negative. What is the most appropriate treatment?", "options": ["High-dose IV methylprednisolone alone for presumed idiopathic transverse myelitis", "IV ceftriaxone 2 g daily for 4 weeks without steroids", "IV ceftriaxone 2 g daily plus high-dose IV methylprednisolone", "Oral doxycycline 100 mg BID for 28 days plus high-dose oral prednisone taper", "Plasma exchange for 5-7 sessions followed by IV ceftriaxone"], "answer": "B", "answer_index": 1, "explanation": "This is Lyme neuroborreliosis with meningomyelitis confirmed by elevated CSF Lyme antibody index and appropriate clinical picture; standard treatment is prolonged IV ceftriaxone without routine adjunctive steroids. Steroids alone (A) are inappropriate and may worsen infection. Adding high-dose steroids to antibiotics (C) has no proven benefit and may be harmful. Oral doxycycline (D) is inadequate for CNS parenchymal involvement. Plasma exchange (E) is used in severe autoimmune demyelination (e.g., NMO, ADEM) and is not indicated here once Lyme is confirmed.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: Endemic Lyme region, prior erythema migrans, progressive myelopathy with leptomeningeal enhancement, elevated CSF Lyme antibody index, and CSF lymphocytic pleocytosis with elevated protein. The clinical picture is Lyme meningomyelitis. The standard of care for Lyme neuroborreliosis with CNS parenchymal involvement (myelitis) is IV ceftriaxone for 2-4 weeks. However, in severe spinal cord inflammation with significant neurologic deficits, adjunctive high-dose corticosteroids are often used empirically to reduce inflammation while antibiotics treat the infection, despite lack of robust trial data. Option C (IV ceftriaxone plus steroids) is a defensible best answer in this severe, progressive case, making the provided key (B, antibiotics alone) not uniquely best. Main logical issue: Key mismatch. Main medical accuracy issue: The keyed answer (B) is not incorrect, but option C is equally or more appropriate given the severity. Minimal fix: Change the key to C, or revise the stem to specify 'without significant cord edema' to favor B.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: Endemic Lyme region, prior erythema migrans, progressive myelopathy with leptomeningeal enhancement, elevated CSF Lyme antibody index, and CSF lymphocytic pleocytosis with elevated protein. The clinical picture is Lyme meningomyelitis. The standard of care for Lyme neuroborreliosis with CNS parenchymal involvement (myelitis) is IV ceftriaxone for 2-4 weeks. However, in severe spinal cord inflammation with significant neurologic deficits, adjunctive high-dose corticosteroids are often used empirically to reduce inflammation while antibiotics treat the infection, despite lack of robust trial data. Option C (IV ceftriaxone plus steroids) is a defensible best answer in this severe, progressive case, making the provided key (B, antibiotics alone) not uniquely best. Main logical issue: Key mismatch. Main medical accuracy issue: The keyed answer (B) is not incorrect, but option C is equally or more appropriate given the severity. Minimal fix: Change the key to C, or revise the stem to specify 'without significant cord edema' to favor B.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-010", "question": "A 48-year-old woman with seropositive rheumatoid arthritis (RF and anti-CCP positive) on methotrexate and adalimumab presents with subacute dyspnea and nonproductive cough. She has never smoked. Vitals: HR 104, BP 118/70, RR 22, SpO2 91% RA. Exam: fine bibasilar crackles, no wheezing, active small-joint synovitis. PFTs: FVC 58% predicted, FEV1/FVC 0.86, DLCO 35% predicted. HRCT: basilar-predominant reticulation, traction bronchiectasis, and patchy subpleural honeycombing consistent with usual interstitial pneumonia (UIP); no nodules or pleural effusions. Which of the following is the most appropriate disease-modifying management change?", "options": ["Continue methotrexate and adalimumab and add low-dose prednisone", "Discontinue methotrexate and switch adalimumab to rituximab", "Stop adalimumab and start tocilizumab while continuing methotrexate", "Continue current RA regimen and initiate mycophenolate mofetil for lung disease", "Add nintedanib while continuing methotrexate and adalimumab unchanged"], "answer": "B", "answer_index": 1, "explanation": "She has RA-associated ILD with a UIP pattern, in which methotrexate and TNF inhibitors are relatively contraindicated due to concerns for ILD progression; rituximab is preferred as an RA biologic in ILD. Continuing MTX/TNF with steroids (A) risks worsening lung fibrosis. Tocilizumab (C) has less data and does not address TNF-risk concerns. Adding mycophenolate (D) without removing potential pulmonary offenders is suboptimal. Nintedanib (E) may be beneficial in progressive fibrosing RA-ILD, but first-line is to remove MTX/TNF and choose an ILD-favorable biologic such as rituximab.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: RA-ILD with UIP pattern on HRCT, subacute dyspnea, low DLCO, and current methotrexate/TNF inhibitor therapy. The logical issue is that while discontinuing methotrexate is a standard, evidence-based step in this scenario, the stem does not provide a clear, unique reason to switch to rituximab over other ILD-favorable biologics (e.g., abatacept, tocilizumab) or to choose it over adding an antifibrotic like nintedanib. The keyed answer (B) is a reasonable option but not uniquely defensible as 'most appropriate' without additional clinical context (e.g., progressive fibrosis, joint activity). Medical accuracy is sound regarding methotrexate/TNF inhibitor risk. Minimal fix: Specify 'progressive fibrosing ILD despite current therapy' to justify rituximab as the clear next step.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: RA-ILD with UIP pattern on HRCT, subacute dyspnea, low DLCO, and current methotrexate/TNF inhibitor therapy. The logical issue is that while discontinuing methotrexate is a standard, evidence-based step in this scenario, the stem does not provide a clear, unique reason to switch to rituximab over other ILD-favorable biologics (e.g., abatacept, tocilizumab) or to choose it over adding an antifibrotic like nintedanib. The keyed answer (B) is a reasonable option but not uniquely defensible as 'most appropriate' without additional clinical context (e.g., progressive fibrosis, joint activity). Medical accuracy is sound regarding methotrexate/TNF inhibitor risk. Minimal fix: Specify 'progressive fibrosing ILD despite current therapy' to justify rituximab as the clear next step.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}]